Cognition Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$25,788,000 over the previous period. Total operating expenses were $50,724,000.
Profit Margin
| 2019 | 0 | -6.95M | |
|---|---|---|---|
| 2020 | 0 | -10.07M | |
| 2021 | 0 | -10.28M | |
| 2022 | 0 | 757K | |
| 2023 | 0 | -25.78M |
CGTX Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 252K | 235K | 93K | 98K | 81K |
Gross profit | -252K | -235K | -93K | -98K | -81K |
Operating exp. | |||||
Research and development | 37.19M | 30.32M | 18.57M | 12.88M | 14.37M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 50.72M | 21.33M | 11.15M | 6.55M | 4.66M |
Operating income | -50.72M | -43.55M | -28.59M | -17.40M | -17.83M |
Other income (expenses), net | 24.93M | 22.15M | 16.88M | 9.56M | 12.98M |
Income before tax | -25.78M | -21.39M | -11.71M | -7.83M | -4.84M |
Income tax expense | 0 | -22.15M | -1.43M | 2.23M | 2.11M |
Net income | -25.78M | 757K | -10.28M | -10.07M | -6.95M |
Earnings per share | |||||
Basic EPS | -0.86 | 0.02 | -0.46 | -0.46 | -0.32 |
Diluted EPS | -0.86 | 0.02 | -0.46 | -0.46 | -0.32 |
| Data source | Data source | Data source |